The societal burden of spinal conditions is vast and continues to grow with the in- creasing prevalence of patients with spinal degenerative disease, spinal metasta- ses, and spinal infections.... Show moreThe societal burden of spinal conditions is vast and continues to grow with the in- creasing prevalence of patients with spinal degenerative disease, spinal metasta- ses, and spinal infections. Recent application of artificial intelligence in healthcare have shown great promise and similar extensions in spine surgery may improve decision-making. The purpose of this thesis was to examine the utility of predictive analytics and natural language processing in spine surgery. Show less
The aim of this thesis is to determine diagnostic performance of machine learning in differentiating between atypical cartilaginous tumor (ACT) and high-grade chondrosarcoma (CS) based on radiomic... Show moreThe aim of this thesis is to determine diagnostic performance of machine learning in differentiating between atypical cartilaginous tumor (ACT) and high-grade chondrosarcoma (CS) based on radiomic features derived from magnetic resonance imaging (MRI) and computed tomography (CT). In chapter 2, the concept of radiomics of musculoskeletal sarcomas is introduced and a systematic review on radiomic feature reproducibility and validation strategies is conducted. In chapter 3, a preliminary study is performed to investigate the performance of MRI radiomics-based machine learning in discriminating ACT from high-grade CS, using a single-center cohort, in comparison with an expert radiologist. In chapter 4, the influence of interobserver segmentation variability on the reproducibility of CT and MRI radiomic features of cartilaginous bone tumors is assessed. In chapter 5, the performance of CT radiomics-based machine learning in discriminating ACT from high-grade CS of long bones is determined and validated using independent data from a multicenter cohort, compared to an expert radiologist. In chapter 6, the performance of MRI radiomics-based machine learning in differentiating between ACT and grade II CS of long bones is determined and validated using independent data from a multicenter cohort, in comparison with an expert radiologist. Finally, in chapter 7, the main results and implications of this thesis are summarized and discussed. Show less
Despite improved surgical and adjuvant treatment options, malignant brain tumors remain non-curable to date. The thin line between treatment effectiveness and patient harms underpins the importance... Show moreDespite improved surgical and adjuvant treatment options, malignant brain tumors remain non-curable to date. The thin line between treatment effectiveness and patient harms underpins the importance of tailoring clinical management to the individual brain tumor patient. Over the past decades, the volume and complexity of clinically-derived patient data (i.e., imaging, genomics, free-text etc.) is increasing exponentially. Machine learning provides a vast range of algorithms that can learn from this data and guide clinical decision-making by providing accurate patient-level predictions. The current thesis describes several studies along the continuum of the machine learning spectrum as it applies to neurosurgical oncology. Part I investigates postoperative complications and risk factors in patients operated for a primary malignant brain tumor. Part II describes de development of a model for the prediction of individual-patient survival in glioblastoma patients. Part III encompasses the development of a natural language processing framework for automated medical text analysis. Machine learning algorithms should be considered as an extension to statistical approaches and exist along a continuum determined by how much is specified by humans and how much is learnt by the machine. Although machine learning algorithms can produce highly accurate predictions based on high-dimensional data, clinicians and researchers should interpret the clinical implications of these predictions on case-by-case basis. Show less
Pharmacogenomics (PGx) is widely recognized as an important aspect in personalizedMedicine. By analyzing and interpreting one’s genetic profile dose and drug adjustmentscan be made. In this way,... Show morePharmacogenomics (PGx) is widely recognized as an important aspect in personalizedMedicine. By analyzing and interpreting one’s genetic profile dose and drug adjustmentscan be made. In this way, one can strive to improve the safety and efficacy of drugtreatments. Nonetheless, not all genetic variability in drug response can be explained withcurrent PGx. In this thesis we explore the role of additional genetic factors which can explain this missing heritability. Firstly, rare and novel variants which are unaccounted for in routine PGx panels might play a role. Secondly, the complexity of pharmacogenes can result in an inability tounravel the genetic make-up of these genes. Thirdly, haplotype phasing is generally nottaken into account in PGx. Fourthly, all genetic variants are currently summarized intoone of four metabolic categories: poor metabolizers (PM), intermediate metabolizers(IM), normal metabolizers (NM) (previously EM) and ultra-rapid metabolizers (UM).However, enzyme activity is not a matter of ‘on’ or ‘off ’, but is more of a continuous scale.Finally, the effect of a genetic variant on drug metabolism shows substrate specific effects.This substrate specificity can result in erroneous extrapolation of variant effects to theentire range of substrates. The development of novel technologies to determine one’sgenetic make-up is evolving rapidly, thereby providing opportunities for the field of PGxto address these issues. In this thesis we show that by using long-read sequencing or trio-based sequencing more information can be obtained which can lead to a better understanding of the (rare) variants and can help with haplotype phasing. Moreover, we have shown that by combining long-read sequencing with artificial intelligence a substantial increase in explained variability can be achieved. Show less